Wednesday, July 22, 2009
Removal Of Tonsils And Adenoids Associated With Ongoing Benefits For Children With Breathing Problems During Sleep
Tuesday, July 21, 2009
New Molecular Pathway For Targeting Cancer Discovered
A UCLA study has identified a way to turn off a key signaling pathway involved in physiological processes that can also stimulate the development of cancer and other diseases.
A UCLA study has identified a way to turn off a key signaling pathway involved in physiological processes that can also stimulate the development of cancer and other diseases. The findings may lead to new treatments and targeted drugs using this approach.
HGS BLISSful with Early Results in Lupus Drug Study
Human Genome Sciences (HGS) Inc announced early results in BLISS-52 trial using BENLYSTA (belimumab, formerly LymphoStat-B). The results have left them blissful as the study results showed patients who took Benlysta demonstrated a statistically significant improvement in the symptoms of their disease compared with those taking a placebo.
Human Genome Sciences (HGS) Inc announced early results in BLISS-52 trial using BENLYSTA (belimumab, formerly LymphoStat-B). The results have left them blissful as the study results showed patients who took Benlysta demonstrated a statistically significant improvement in the symptoms of their disease compared with those taking a placebo.